| Literature DB >> 9447334 |
Abstract
The GUSTO trials have provided continuing insight into the complexities of a simple fundamental relationship: early and sustained coronary perfusion in patients with acute myocardial infarction leads to lower mortality and morbidity. To a large extent, the GUSTO trials have attempted to develop approaches to therapy that will ensure the highest early rate of reperfusion with the least risk. A table provides a summary of the completed trials and those that are planned in attempts to provide further knowledge in the continuing quest to improve the plight of patients with acute myocardial infarction.Entities:
Mesh:
Year: 1997 PMID: 9447334 DOI: 10.1093/eurheartj/18.suppl_f.2
Source DB: PubMed Journal: Eur Heart J ISSN: 0195-668X Impact factor: 29.983